KalshiKullanılabilirliği kontrol etKYC gerekli%2 ücretDoğrulanmış sonuçlanma verisiKabaca kalibreGüncel ima edilen olasılıkbefore April 2027 67%6 seçenek arasında lider
Piyasa kalitesi
37 / 100
Düşük kalite24s Hacim
₺0
Likidite
₺106,8 B
Düşük likiditeAlis / Satis
3.0% / 10.0%
Spread
7.0 pt
Geniş spreadPiyasa verileri
16 dakika önce guncellendi
24 Mar 26 14:001 Eyl 26 14:00
Trendler
0%
Yalnızca sanal bakiye, gerçek para yokYatırım tavsiyesi değildir
Seçilen sonuç
before September10%
Hacim trendi
$124 Tem13g veri25 Tem
İlgili Piyasalar
Testosterone unscheduled/rescheduled more permissively in US by end of 2028?
₺27,6 BEvet: 17.8%MANIFOLD MARKETS
MANIFOLD MARKETSWill there be a cure for schizophrenia before 2032?
₺23,7 BEvet: 11.8%MANIFOLD MARKETS
MANIFOLD MARKETSWill artificial blood be used to treat a patient by the end of 2026?
₺23,7 BEvet: 9.7%MANIFOLD MARKETS
MANIFOLD MARKETS
Will there be a year without polio before 2030?
₺831,9Evet: 6%KALSHI
KALSHI
Hantavirus vaccine in 2026?
₺49,7Evet: 6%
POLYMARKET
POLYMARKET
When will Intellia Therapeutics submit a BLA for Lonvo-z?
₺0before September: 22%KALSHI
KALSHIBu konularda aktif
İlgili Haberler
NVIDIA Ising Calibration 1.5 Pushes Quantum Computing ForwardBlockchain.News
Crypto is the canary in the coal mine for the quantum computing threat, experts sayCoindesk
Galaxy Digital opens $5M fund for Bitcoin quantum security researchCrypto News
Claude's Fable 5 just solved an 87-year-old math problem, and it matters for bitcoinCoindesk
Google DeepMind, Isomorphic Labs Unveil AI-Powered Bioresilience PlanBlockchain.NewsNVIDIA's Ising Decoder Slashes Color Code Errors 300xBlockchain.NewsKurallar
If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Sep 1, 2026, then the market resolves to Yes.
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Oct 1, 2026, then the market resolves to Yes.
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Nov 1, 2026, then the market resolves to Yes.
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Dec 1, 2026, then the market resolves to Yes.
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Jan 1, 2027, then the market resolves to Yes.
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Apr 1, 2027, then the market resolves to Yes.